Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00207259 · ClinicalTrials.gov registry record · NA
Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00207259 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 60 participants.
The verdict
NCT00207259, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Randomized clinical study of two CAM therapies, 1) Reiki and 2) Relaxation Response Therapy with Cognitive Restructuring counseling (RRT with CR), compared to an education-only control arm in patients about to begin an eight-week course of external beam radiotherapy (EBRx) for prostate cancer. Generally, we would like to examine the feasibility of studying Reiki and RRT with CR in patients with prostate cancer, and to obtain preliminary results on the effectiveness of these treatments compared to controls. Specific objectives: 1. Determine the proportion of eligible patients who agree to participate in the study 2. Measure compliance with CAM therapy interventions 3. Measure compliance with physiologic and psychological outcome measurement assessments 4. Assess differences between experimental and control groups on measures on depression, anxiety, quality of life, salivary cortisol levels and an immunomarkers
Interventions
- BEHAVIORAL Reiki & Relaxation Response Therapy with Cognitive Restructuring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2005-03 |
| Est. Completion | 2017-06-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00207259
The ClinicalTrials.gov registry entry for NCT00207259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reiki & Relaxation Response Therapy with Cognitive Restructuring is the first listed.
NCT00207259 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00207259 about?
NCT00207259 is a clinical study titled "Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial". Randomized clinical study of two CAM therapies, 1) Reiki and 2) Relaxation Response Therapy with Cognitive Restructuring counseling (RRT with CR), compared to an education-only control arm in patients about to begin an eight-week course of external beam radiotherapy (EBRx) for prostate cancer. Gene...
What is the current status of trial NCT00207259?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2005-03. Estimated completion is 2017-06-15.
What interventions are being tested in trial NCT00207259?
The interventions under investigation include: Reiki & Relaxation Response Therapy with Cognitive Restructuring (BEHAVIORAL).
Who is sponsoring clinical trial NCT00207259?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.